April 30, 2020 / 12:31 PM / a month ago

BRIEF-Genocea Biosciences Inc - Expect Gen-009 Phase 1/2A Part B Readout In Q3

April 30 (Reuters) - Genocea Biosciences Inc:

* GENOCEA BIOSCIENCES INC - EXPECT GEN-009 PHASE 1/2A PART B READOUT IN Q3

* GENOCEA BIOSCIENCES INC - CLINICAL STAGE PROGRAMS GEN-009 AND GEN-011 CONTINUE TO ADVANCE ANTICIPATE GEN-011 IND FILING IN Q2

* GENOCEA BIOSCIENCES INC - GEN-011 VIRTUAL SYMPOSIUM PLANNED FOR MAY 12TH

* GENOCEA BIOSCIENCES- EXPECTS THAT ITS EXISTING CASH AND CASH EQUIVALENTS ARE SUFFICIENT TO SUPPORT ITS OPERATIONS INTO THE Q1 OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below